Anti-TGFB1/ CED/ DPD1 monoclonal antibody

Anti-TGFB1/ CED/ DPD1 antibody for FACS & in-vivo assay

Target products collectionGo to TGFB1/TGFB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T97257-Ab-1/ GM-Tg-hg-T97257-Ab-2Anti-Human TGFB1 monoclonal antibodyHuman
GM-Tg-rg-T97257-Ab-1/ GM-Tg-rg-T97257-Ab-2Anti-Rat TGFB1 monoclonal antibodyRat
GM-Tg-mg-T97257-Ab-1/ GM-Tg-mg-T97257-Ab-2Anti-Mouse TGFB1 monoclonal antibodyMouse
GM-Tg-cynog-T97257-Ab-1/ GM-Tg-cynog-T97257-Ab-2Anti-Cynomolgus/ Rhesus macaque TGFB1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T97257-Ab-1/ GM-Tg-felg-T97257-Ab-2Anti-Feline TGFB1 monoclonal antibodyFeline
GM-Tg-cang-T97257-Ab-1/ GM-Tg-cang-T97257-Ab-2Anti-Canine TGFB1 monoclonal antibodyCanine
GM-Tg-bovg-T97257-Ab-1/ GM-Tg-bovg-T97257-Ab-2Anti-Bovine TGFB1 monoclonal antibodyBovine
GM-Tg-equg-T97257-Ab-1/ GM-Tg-equg-T97257-Ab-2Anti-Equine TGFB1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T97257-Ab-1/ GM-Tg-hg-T97257-Ab-2; GM-Tg-rg-T97257-Ab-1/ GM-Tg-rg-T97257-Ab-2;
GM-Tg-mg-T97257-Ab-1/ GM-Tg-mg-T97257-Ab-2; GM-Tg-cynog-T97257-Ab-1/ GM-Tg-cynog-T97257-Ab-2;
GM-Tg-felg-T97257-Ab-1/ GM-Tg-felg-T97257-Ab-2; GM-Tg-cang-T97257-Ab-1/ GM-Tg-cang-T97257-Ab-2;
GM-Tg-bovg-T97257-Ab-1/ GM-Tg-bovg-T97257-Ab-2; GM-Tg-equg-T97257-Ab-1/ GM-Tg-equg-T97257-Ab-2
Products NameAnti-TGFB1 monoclonal antibody
Formatmab
Target NameTGFB1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TGFB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-223Pre-Made Fresolimumab biosimilar, Whole mAb, Anti-TGFB/TGFB1 Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody
    BiosimilarGMP-Bios-INN-793Pre-Made Dalutrafusp Alfa P Alfaiosimilar, Bispecific, Anti-NT5E/CD73;TGFB1;TGFB3 Antibody: Anti-eN/NTE/eNT/CALJA;CED/DPD1/IBDIMDE/LAP/TGF-beta1/TGFbeta;ARVD/ARVD1/LDS5/RNHF therapeutic antibody
    BiosimilarGMP-Bios-INN-908Pre-Made Metelimumab Biosimilar, Whole Mab, Anti-Tgfb1 Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody
    Target AntigenProducts DevelopingMulti-species TGFB1/ CED/ DPD1 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T97257-Ag-1transforming growth factor, beta 1 (TGFB1) protein
    ORF Viral VectorvGMLP001905human TGFB1 Lentivirus particle
    ORF Viral VectorpGMLP001905human TGFB1 Lentivirus plasmid
    ORF Viral VectorvGMAD000018human TGFB1 Adenovirus particle
    ORF Viral VectorpGMAD000018human TGFB1 Adenovirus plasmid
    ORF Viral VectorvGMAD000417human TGFB1 Adenovirus particle
    ORF Viral VectorpGMAD000417human TGFB1 Adenovirus plasmid
    ORF Viral VectorpGMAP000212human Adenovirus plasmid
    ORF Viral VectorvGMAP000212human Adenovirus particle
    ORF Viral VectorpGMLV000137mouse Tgfb1 Lentivirus plasmid
    ORF Viral VectorpGMLV000138mouse Tgfb1 Lentivirus plasmid
    ORF Viral VectorvGMLV000137mouse Tgfb1 Lentivirus particle
    ORF Viral VectorvGMLV000138mouse Tgfb1 Lentivirus particle


    Target information

    Target IDGM-T97257
    Target NameTGFB1
    Gene ID7040,21803,59086,106992315,403998,768263,282089,100033900
    Gene Symbol and SynonymsCED,DPD1,IBDIMDE,LAP,TGF-beta,TGF-beta1,TGFB,Tgfb-1,TGFB1,TGFbeta,TGFbeta1
    Uniprot AccessionP01137,P17246,P54831,P18341,O19011
    Uniprot Entry NameTGFB1_HUMAN,TGFB1_RAT,TGFB1_CANLF,TGFB1_BOVIN,TGFB1_HORSE
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target
    Diseasebladder cancer, Chronic Kidney Disease, Diabetic Nephropathy, Type 2 diabetes mellitus, Type 1 diabetes mellitus, Sickle Cell Nephropathy, Renal tubulo-interstitial diseases, Malignant neoplasm of bladder, Lupus Glomerulonephritis, Kidney disease
    Gene EnsemblENSG00000105329
    Target ClassificationCheckpoint-Immuno Oncology

    The target: TGFB1, gene name: TGFB1, also named as CED, DPD1, LAP, TGFB, TGFbeta. This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.